ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
  • Category
  • Region
U.S. (TOLL FREE)
+1 (315) 215-3225
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Alinia (nitazoxanide) Market Research Report 2025
Published Date: February 2025
|
Report Code: QYRE-Auto-39P9003
Home | Market Reports | Health| Pharmacy
Global Alinia nitazoxanide Market Insights and Forecast to 2028
BUY CHAPTERS

Global Alinia (nitazoxanide) Market Research Report 2025

Code: QYRE-Auto-39P9003
Report
February 2025
Pages:74
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Romark Laboratories
Chugai Pharmaceutical
Lupin Ltd
Rising
Zenara

Alinia (nitazoxanide) Market Size

The global market for Alinia (nitazoxanide) was valued at US$ 191 million in the year 2024 and is projected to reach a revised size of US$ 240 million by 2031, growing at a CAGR of 3.3% during the forecast period.

Alinia (nitazoxanide) Market

Alinia (nitazoxanide) Market

Nitazoxanide, sold under the brand name Alinia among others, Nitazoxanide is an antiprotozoal medicine that treats infections caused by protozoa (single-cell parasites that live in moist places such as lakes, streams, and soil). Nitazoxanide is used to treat diarrhea caused by Giardia or Cryptosporidium. These conditions are sometimes called "Traveler's diarrhea." Nitazoxanide is used in adults and children who are at least 1 year old.
The Alinia (nitazoxanide) market is primarily driven by the increasing prevalence of parasitic infections and gastrointestinal diseases worldwide. Nitazoxanide, a broad-spectrum anti-parasitic and anti-protozoal drug, is effective in treating infections like giardiasis, amebiasis, and other intestinal parasitic infections. The growing awareness of these diseases, especially in regions with poor sanitation and healthcare infrastructure, contributes to the demand for Alinia. Additionally, its effectiveness against a range of pathogens, including protozoa and some viral infections, positions it as a vital treatment option for physicians in endemic areas. As international health organizations push for better treatment solutions for neglected tropical diseases, the global need for Alinia continues to rise.
However, the Alinia market faces challenges related to its high cost and limited availability in certain regions. While nitazoxanide is effective, its price may be prohibitive for patients in low-income countries, where parasitic infections are most prevalent. This pricing issue is further compounded by competition from cheaper generic alternatives and the availability of other medications for similar conditions. Moreover, despite its broad-spectrum efficacy, Alinia’s usage is limited to specific conditions, and it is not always the first-line treatment, especially in more developed regions where other, more widely used drugs are available. Additionally, regulatory hurdles and approval processes in certain markets could hinder broader adoption, particularly in developing countries where access to essential medicines remains a challenge.
The key players of Alinia (nitazoxanide) include Romark Laboratories, Chugai Pharmaceutical, Lupin etc. The top three players of Alinia (nitazoxanide) account for approximately 45% of the total global market. Asia-Pacific is the largest consumer market of Alinia (nitazoxanide) accounting for about 45% followed by South America and Europe. In terms of Type, Tablets is the largest segment, with a share about 99%. And in terms of Application, the largest application is Hospital followed by Retail Pharmacy.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Alinia (nitazoxanide), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Alinia (nitazoxanide).
The Alinia (nitazoxanide) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Alinia (nitazoxanide) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Alinia (nitazoxanide) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Alinia (nitazoxanide) Market Report

Report Metric Details
Report Name Alinia (nitazoxanide) Market
Accounted market size in year US$ 191 million
Forecasted market size in 2031 US$ 240 million
CAGR 3.3%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Tablets
  • Oral Suspension
Segment by Application
  • Retail Pharmacy
  • Hospital
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Romark Laboratories, Chugai Pharmaceutical, Lupin, RISING, ZENARA
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Alinia (nitazoxanide) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Alinia (nitazoxanide) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Alinia (nitazoxanide) Market growing?

Ans: The Alinia (nitazoxanide) Market witnessing a CAGR of 3.3% during the forecast period 2025-2031.

What is the Alinia (nitazoxanide) Market size in 2031?

Ans: The Alinia (nitazoxanide) Market size in 2031 will be US$ 240 million.

What is the market share of major companies in Alinia (nitazoxanide) Market?

Ans: The top three players of Alinia (nitazoxanide) account for approximately 45% of the total global market.

What is the Alinia (nitazoxanide) Market share by type?

Ans: In terms of Type, Tablets is the largest segment, with a share about 99%.

Who are the main players in the Alinia (nitazoxanide) Market report?

Ans: The main players in the Alinia (nitazoxanide) Market are Romark Laboratories, Chugai Pharmaceutical, Lupin, RISING, ZENARA

What are the Application segmentation covered in the Alinia (nitazoxanide) Market report?

Ans: The Applications covered in the Alinia (nitazoxanide) Market report are Retail Pharmacy, Hospital, Others

What are the Type segmentation covered in the Alinia (nitazoxanide) Market report?

Ans: The Types covered in the Alinia (nitazoxanide) Market report are Tablets, Oral Suspension

1 Alinia (nitazoxanide) Market Overview
1.1 Product Definition
1.2 Alinia (nitazoxanide) by Type
1.2.1 Global Alinia (nitazoxanide) Market Value Comparison by Type (2024 VS 2031)
1.2.2 Tablets
1.2.3 Oral Suspension
1.3 Alinia (nitazoxanide) by Application
1.3.1 Global Alinia (nitazoxanide) Market Value by Application (2024 VS 2031)
1.3.2 Retail Pharmacy
1.3.3 Hospital
1.3.4 Others
1.4 Global Alinia (nitazoxanide) Market Size Estimates and Forecasts
1.4.1 Global Alinia (nitazoxanide) Revenue 2020-2031
1.4.2 Global Alinia (nitazoxanide) Sales 2020-2031
1.4.3 Global Alinia (nitazoxanide) Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Alinia (nitazoxanide) Market Competition by Manufacturers
2.1 Global Alinia (nitazoxanide) Sales Market Share by Manufacturers (2020-2025)
2.2 Global Alinia (nitazoxanide) Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Alinia (nitazoxanide) Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Alinia (nitazoxanide), Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Alinia (nitazoxanide), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Alinia (nitazoxanide), Product Type & Application
2.7 Global Key Manufacturers of Alinia (nitazoxanide), Date of Enter into This Industry
2.8 Global Alinia (nitazoxanide) Market Competitive Situation and Trends
2.8.1 Global Alinia (nitazoxanide) Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Alinia (nitazoxanide) Players Market Share by Revenue
2.8.3 Global Alinia (nitazoxanide) Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Alinia (nitazoxanide) Market Scenario by Region
3.1 Global Alinia (nitazoxanide) Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Alinia (nitazoxanide) Sales by Region: 2020-2031
3.2.1 Global Alinia (nitazoxanide) Sales by Region: 2020-2025
3.2.2 Global Alinia (nitazoxanide) Sales by Region: 2026-2031
3.3 Global Alinia (nitazoxanide) Revenue by Region: 2020-2031
3.3.1 Global Alinia (nitazoxanide) Revenue by Region: 2020-2025
3.3.2 Global Alinia (nitazoxanide) Revenue by Region: 2026-2031
3.4 North America Alinia (nitazoxanide) Market Facts & Figures by Country
3.4.1 North America Alinia (nitazoxanide) Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Alinia (nitazoxanide) Sales by Country (2020-2031)
3.4.3 North America Alinia (nitazoxanide) Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Alinia (nitazoxanide) Market Facts & Figures by Country
3.5.1 Europe Alinia (nitazoxanide) Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Alinia (nitazoxanide) Sales by Country (2020-2031)
3.5.3 Europe Alinia (nitazoxanide) Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Alinia (nitazoxanide) Market Facts & Figures by Region
3.6.1 Asia Pacific Alinia (nitazoxanide) Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Alinia (nitazoxanide) Sales by Region (2020-2031)
3.6.3 Asia Pacific Alinia (nitazoxanide) Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Alinia (nitazoxanide) Market Facts & Figures by Country
3.7.1 Latin America Alinia (nitazoxanide) Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Alinia (nitazoxanide) Sales by Country (2020-2031)
3.7.3 Latin America Alinia (nitazoxanide) Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Alinia (nitazoxanide) Market Facts & Figures by Country
3.8.1 Middle East and Africa Alinia (nitazoxanide) Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Alinia (nitazoxanide) Sales by Country (2020-2031)
3.8.3 Middle East and Africa Alinia (nitazoxanide) Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Alinia (nitazoxanide) Sales by Type (2020-2031)
4.1.1 Global Alinia (nitazoxanide) Sales by Type (2020-2025)
4.1.2 Global Alinia (nitazoxanide) Sales by Type (2026-2031)
4.1.3 Global Alinia (nitazoxanide) Sales Market Share by Type (2020-2031)
4.2 Global Alinia (nitazoxanide) Revenue by Type (2020-2031)
4.2.1 Global Alinia (nitazoxanide) Revenue by Type (2020-2025)
4.2.2 Global Alinia (nitazoxanide) Revenue by Type (2026-2031)
4.2.3 Global Alinia (nitazoxanide) Revenue Market Share by Type (2020-2031)
4.3 Global Alinia (nitazoxanide) Price by Type (2020-2031)
5 Segment by Application
5.1 Global Alinia (nitazoxanide) Sales by Application (2020-2031)
5.1.1 Global Alinia (nitazoxanide) Sales by Application (2020-2025)
5.1.2 Global Alinia (nitazoxanide) Sales by Application (2026-2031)
5.1.3 Global Alinia (nitazoxanide) Sales Market Share by Application (2020-2031)
5.2 Global Alinia (nitazoxanide) Revenue by Application (2020-2031)
5.2.1 Global Alinia (nitazoxanide) Revenue by Application (2020-2025)
5.2.2 Global Alinia (nitazoxanide) Revenue by Application (2026-2031)
5.2.3 Global Alinia (nitazoxanide) Revenue Market Share by Application (2020-2031)
5.3 Global Alinia (nitazoxanide) Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Romark Laboratories
6.1.1 Romark Laboratories Company Information
6.1.2 Romark Laboratories Description and Business Overview
6.1.3 Romark Laboratories Alinia (nitazoxanide) Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Romark Laboratories Alinia (nitazoxanide) Product Portfolio
6.1.5 Romark Laboratories Recent Developments/Updates
6.2 Chugai Pharmaceutical
6.2.1 Chugai Pharmaceutical Company Information
6.2.2 Chugai Pharmaceutical Description and Business Overview
6.2.3 Chugai Pharmaceutical Alinia (nitazoxanide) Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Chugai Pharmaceutical Alinia (nitazoxanide) Product Portfolio
6.2.5 Chugai Pharmaceutical Recent Developments/Updates
6.3 Lupin
6.3.1 Lupin Company Information
6.3.2 Lupin Description and Business Overview
6.3.3 Lupin Alinia (nitazoxanide) Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Lupin Alinia (nitazoxanide) Product Portfolio
6.3.5 Lupin Recent Developments/Updates
6.4 RISING
6.4.1 RISING Company Information
6.4.2 RISING Description and Business Overview
6.4.3 RISING Alinia (nitazoxanide) Sales, Revenue and Gross Margin (2020-2025)
6.4.4 RISING Alinia (nitazoxanide) Product Portfolio
6.4.5 RISING Recent Developments/Updates
6.5 ZENARA
6.5.1 ZENARA Company Information
6.5.2 ZENARA Description and Business Overview
6.5.3 ZENARA Alinia (nitazoxanide) Sales, Revenue and Gross Margin (2020-2025)
6.5.4 ZENARA Alinia (nitazoxanide) Product Portfolio
6.5.5 ZENARA Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Alinia (nitazoxanide) Industry Chain Analysis
7.2 Alinia (nitazoxanide) Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Alinia (nitazoxanide) Production Mode & Process Analysis
7.4 Alinia (nitazoxanide) Sales and Marketing
7.4.1 Alinia (nitazoxanide) Sales Channels
7.4.2 Alinia (nitazoxanide) Distributors
7.5 Alinia (nitazoxanide) Customer Analysis
8 Alinia (nitazoxanide) Market Dynamics
8.1 Alinia (nitazoxanide) Industry Trends
8.2 Alinia (nitazoxanide) Market Drivers
8.3 Alinia (nitazoxanide) Market Challenges
8.4 Alinia (nitazoxanide) Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Romark Laboratories
Chugai Pharmaceutical
Lupin Ltd
Rising
Zenara
List of Tables
 Table 1. Global Alinia (nitazoxanide) Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Alinia (nitazoxanide) Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Alinia (nitazoxanide) Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Alinia (nitazoxanide) Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Alinia (nitazoxanide) Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Alinia (nitazoxanide) Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Alinia (nitazoxanide) Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Alinia (nitazoxanide) Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Alinia (nitazoxanide), Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Alinia (nitazoxanide), Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Alinia (nitazoxanide), Product Type & Application
 Table 12. Global Key Manufacturers of Alinia (nitazoxanide), Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Alinia (nitazoxanide) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alinia (nitazoxanide) as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Alinia (nitazoxanide) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Alinia (nitazoxanide) Sales by Region (2020-2025) & (K Units)
 Table 18. Global Alinia (nitazoxanide) Sales Market Share by Region (2020-2025)
 Table 19. Global Alinia (nitazoxanide) Sales by Region (2026-2031) & (K Units)
 Table 20. Global Alinia (nitazoxanide) Sales Market Share by Region (2026-2031)
 Table 21. Global Alinia (nitazoxanide) Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Alinia (nitazoxanide) Revenue Market Share by Region (2020-2025)
 Table 23. Global Alinia (nitazoxanide) Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Alinia (nitazoxanide) Revenue Market Share by Region (2026-2031)
 Table 25. North America Alinia (nitazoxanide) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Alinia (nitazoxanide) Sales by Country (2020-2025) & (K Units)
 Table 27. North America Alinia (nitazoxanide) Sales by Country (2026-2031) & (K Units)
 Table 28. North America Alinia (nitazoxanide) Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Alinia (nitazoxanide) Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Alinia (nitazoxanide) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Alinia (nitazoxanide) Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Alinia (nitazoxanide) Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Alinia (nitazoxanide) Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Alinia (nitazoxanide) Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Alinia (nitazoxanide) Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Alinia (nitazoxanide) Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Alinia (nitazoxanide) Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Alinia (nitazoxanide) Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Alinia (nitazoxanide) Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Alinia (nitazoxanide) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Alinia (nitazoxanide) Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Alinia (nitazoxanide) Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Alinia (nitazoxanide) Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Alinia (nitazoxanide) Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Alinia (nitazoxanide) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Alinia (nitazoxanide) Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Alinia (nitazoxanide) Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Alinia (nitazoxanide) Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Alinia (nitazoxanide) Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Alinia (nitazoxanide) Sales (K Units) by Type (2020-2025)
 Table 51. Global Alinia (nitazoxanide) Sales (K Units) by Type (2026-2031)
 Table 52. Global Alinia (nitazoxanide) Sales Market Share by Type (2020-2025)
 Table 53. Global Alinia (nitazoxanide) Sales Market Share by Type (2026-2031)
 Table 54. Global Alinia (nitazoxanide) Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Alinia (nitazoxanide) Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Alinia (nitazoxanide) Revenue Market Share by Type (2020-2025)
 Table 57. Global Alinia (nitazoxanide) Revenue Market Share by Type (2026-2031)
 Table 58. Global Alinia (nitazoxanide) Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Alinia (nitazoxanide) Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Alinia (nitazoxanide) Sales (K Units) by Application (2020-2025)
 Table 61. Global Alinia (nitazoxanide) Sales (K Units) by Application (2026-2031)
 Table 62. Global Alinia (nitazoxanide) Sales Market Share by Application (2020-2025)
 Table 63. Global Alinia (nitazoxanide) Sales Market Share by Application (2026-2031)
 Table 64. Global Alinia (nitazoxanide) Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Alinia (nitazoxanide) Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Alinia (nitazoxanide) Revenue Market Share by Application (2020-2025)
 Table 67. Global Alinia (nitazoxanide) Revenue Market Share by Application (2026-2031)
 Table 68. Global Alinia (nitazoxanide) Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Alinia (nitazoxanide) Price (US$/Unit) by Application (2026-2031)
 Table 70. Romark Laboratories Company Information
 Table 71. Romark Laboratories Description and Business Overview
 Table 72. Romark Laboratories Alinia (nitazoxanide) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Romark Laboratories Alinia (nitazoxanide) Product
 Table 74. Romark Laboratories Recent Developments/Updates
 Table 75. Chugai Pharmaceutical Company Information
 Table 76. Chugai Pharmaceutical Description and Business Overview
 Table 77. Chugai Pharmaceutical Alinia (nitazoxanide) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Chugai Pharmaceutical Alinia (nitazoxanide) Product
 Table 79. Chugai Pharmaceutical Recent Developments/Updates
 Table 80. Lupin Company Information
 Table 81. Lupin Description and Business Overview
 Table 82. Lupin Alinia (nitazoxanide) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Lupin Alinia (nitazoxanide) Product
 Table 84. Lupin Recent Developments/Updates
 Table 85. RISING Company Information
 Table 86. RISING Description and Business Overview
 Table 87. RISING Alinia (nitazoxanide) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. RISING Alinia (nitazoxanide) Product
 Table 89. RISING Recent Developments/Updates
 Table 90. ZENARA Company Information
 Table 91. ZENARA Description and Business Overview
 Table 92. ZENARA Alinia (nitazoxanide) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. ZENARA Alinia (nitazoxanide) Product
 Table 94. ZENARA Recent Developments/Updates
 Table 95. Key Raw Materials Lists
 Table 96. Raw Materials Key Suppliers Lists
 Table 97. Alinia (nitazoxanide) Distributors List
 Table 98. Alinia (nitazoxanide) Customers List
 Table 99. Alinia (nitazoxanide) Market Trends
 Table 100. Alinia (nitazoxanide) Market Drivers
 Table 101. Alinia (nitazoxanide) Market Challenges
 Table 102. Alinia (nitazoxanide) Market Restraints
 Table 103. Research Programs/Design for This Report
 Table 104. Key Data Information from Secondary Sources
 Table 105. Key Data Information from Primary Sources
 Table 106. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Alinia (nitazoxanide)
 Figure 2. Global Alinia (nitazoxanide) Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Alinia (nitazoxanide) Market Share by Type: 2024 & 2031
 Figure 4. Tablets Product Picture
 Figure 5. Oral Suspension Product Picture
 Figure 6. Global Alinia (nitazoxanide) Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Alinia (nitazoxanide) Market Share by Application: 2024 & 2031
 Figure 8. Retail Pharmacy
 Figure 9. Hospital
 Figure 10. Others
 Figure 11. Global Alinia (nitazoxanide) Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Alinia (nitazoxanide) Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Alinia (nitazoxanide) Sales (2020-2031) & (K Units)
 Figure 14. Global Alinia (nitazoxanide) Average Price (US$/Unit) & (2020-2031)
 Figure 15. Alinia (nitazoxanide) Report Years Considered
 Figure 16. Alinia (nitazoxanide) Sales Share by Manufacturers in 2024
 Figure 17. Global Alinia (nitazoxanide) Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Alinia (nitazoxanide) Players: Market Share by Revenue in Alinia (nitazoxanide) in 2024
 Figure 19. Alinia (nitazoxanide) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Alinia (nitazoxanide) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Alinia (nitazoxanide) Sales Market Share by Country (2020-2031)
 Figure 22. North America Alinia (nitazoxanide) Revenue Market Share by Country (2020-2031)
 Figure 23. United States Alinia (nitazoxanide) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Alinia (nitazoxanide) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Alinia (nitazoxanide) Sales Market Share by Country (2020-2031)
 Figure 26. Europe Alinia (nitazoxanide) Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Alinia (nitazoxanide) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Alinia (nitazoxanide) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Alinia (nitazoxanide) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Alinia (nitazoxanide) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Alinia (nitazoxanide) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Alinia (nitazoxanide) Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Alinia (nitazoxanide) Revenue Market Share by Region (2020-2031)
 Figure 34. China Alinia (nitazoxanide) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Alinia (nitazoxanide) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Alinia (nitazoxanide) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Alinia (nitazoxanide) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Alinia (nitazoxanide) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan Alinia (nitazoxanide) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Indonesia Alinia (nitazoxanide) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Thailand Alinia (nitazoxanide) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Malaysia Alinia (nitazoxanide) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Latin America Alinia (nitazoxanide) Sales Market Share by Country (2020-2031)
 Figure 44. Latin America Alinia (nitazoxanide) Revenue Market Share by Country (2020-2031)
 Figure 45. Mexico Alinia (nitazoxanide) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Brazil Alinia (nitazoxanide) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Argentina Alinia (nitazoxanide) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Middle East and Africa Alinia (nitazoxanide) Sales Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa Alinia (nitazoxanide) Revenue Market Share by Country (2020-2031)
 Figure 50. Turkey Alinia (nitazoxanide) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia Alinia (nitazoxanide) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. UAE Alinia (nitazoxanide) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Global Sales Market Share of Alinia (nitazoxanide) by Type (2020-2031)
 Figure 54. Global Revenue Market Share of Alinia (nitazoxanide) by Type (2020-2031)
 Figure 55. Global Alinia (nitazoxanide) Price (US$/Unit) by Type (2020-2031)
 Figure 56. Global Sales Market Share of Alinia (nitazoxanide) by Application (2020-2031)
 Figure 57. Global Revenue Market Share of Alinia (nitazoxanide) by Application (2020-2031)
 Figure 58. Global Alinia (nitazoxanide) Price (US$/Unit) by Application (2020-2031)
 Figure 59. Alinia (nitazoxanide) Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Leap India

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Sustained-release Medicine Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-27L13848
Mon Mar 10 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global TMB Substrates Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35O18945
Mon Mar 10 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global OPD Substrate Tablets Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-16T19098
Mon Mar 10 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Fungal Testing Kit Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-25A7904
Mon Mar 10 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions